🚀 VC round data is live in beta, check it out!
Eurobio Scientific Valuation Multiples
Discover revenue and EBITDA valuation multiples for Eurobio Scientific and similar public comparables like TriSalus Life Sciences, Senseonics Holdings, Australian Clinical Labs, Healius and more.
Eurobio Scientific Overview
About Eurobio Scientific
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
Founded
2018
HQ
Employees
127
Website
Financials (LTM)
EV
$273M
Eurobio Scientific Financials
Eurobio Scientific reported last 12-month revenue of $200M and EBITDA of $34M.
In the same LTM period, Eurobio Scientific generated $34M in EBITDA and $11M in net income.
Revenue (LTM)
Eurobio Scientific P&L
In the most recent fiscal year, Eurobio Scientific reported revenue of $182M and EBITDA of $32M.
Eurobio Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $200M | XXX | $182M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $84M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 46% | XXX | XXX | XXX |
| EBITDA | $34M | XXX | $32M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $11M | XXX | $5M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 3% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Eurobio Scientific Stock Performance
Eurobio Scientific has current market cap of $284M, and enterprise value of $273M.
Market Cap Evolution
Eurobio Scientific's stock price is $28.26.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $273M | $284M | -1.7% | XXX | XXX | XXX | $0.47 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEurobio Scientific Valuation Multiples
Eurobio Scientific trades at 1.4x EV/Revenue multiple, and 8.0x EV/EBITDA.
EV / Revenue (LTM)
Eurobio Scientific Financial Valuation Multiples
As of April 20, 2026, Eurobio Scientific has market cap of $284M and EV of $273M.
Equity research analysts estimate Eurobio Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eurobio Scientific has a P/E ratio of 26.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $284M | XXX | $284M | XXX | XXX | XXX |
| EV (current) | $273M | XXX | $273M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 8.0x | XXX | 8.4x | XXX | XXX | XXX |
| EV/EBIT | 9.2x | XXX | 23.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.2x | XXX | XXX | XXX |
| P/E | 26.7x | XXX | 60.4x | XXX | XXX | XXX |
| EV/FCF | 12.2x | XXX | 17.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Eurobio Scientific Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Eurobio Scientific Margins & Growth Rates
Eurobio Scientific's revenue in the last 12 month grew by 4%.
Eurobio Scientific's revenue per employee in the last FY averaged $1.4M, while opex per employee averaged $0.6M for the same period.
Eurobio Scientific's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eurobio Scientific's rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Eurobio Scientific Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 0% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 19% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Eurobio Scientific Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Eurobio Scientific | XXX | XXX | XXX | XXX | XXX | XXX |
| TriSalus Life Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Senseonics Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Carlsmed | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eurobio Scientific M&A Activity
Eurobio Scientific acquired XXX companies to date.
Last acquisition by Eurobio Scientific was on XXXXXXXX, XXXXX. Eurobio Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Eurobio Scientific
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEurobio Scientific Investment Activity
Eurobio Scientific invested in XXX companies to date.
Eurobio Scientific made its latest investment on XXXXXXXX, XXXXX. Eurobio Scientific invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Eurobio Scientific
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Eurobio Scientific
| When was Eurobio Scientific founded? | Eurobio Scientific was founded in 2018. |
| Where is Eurobio Scientific headquartered? | Eurobio Scientific is headquartered in France. |
| How many employees does Eurobio Scientific have? | As of today, Eurobio Scientific has over 127 employees. |
| Is Eurobio Scientific publicly listed? | Yes, Eurobio Scientific is a public company listed on Euronext Paris. |
| What is the stock symbol of Eurobio Scientific? | Eurobio Scientific trades under ALERS ticker. |
| When did Eurobio Scientific go public? | Eurobio Scientific went public in 2005. |
| Who are competitors of Eurobio Scientific? | Eurobio Scientific main competitors are TriSalus Life Sciences, Senseonics Holdings, Australian Clinical Labs, Healius. |
| What is the current market cap of Eurobio Scientific? | Eurobio Scientific's current market cap is $284M. |
| What is the current revenue of Eurobio Scientific? | Eurobio Scientific's last 12 months revenue is $200M. |
| What is the current revenue growth of Eurobio Scientific? | Eurobio Scientific revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Eurobio Scientific? | Current revenue multiple of Eurobio Scientific is 1.4x. |
| Is Eurobio Scientific profitable? | Yes, Eurobio Scientific is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Eurobio Scientific? | Eurobio Scientific's last 12 months EBITDA is $34M. |
| What is Eurobio Scientific's EBITDA margin? | Eurobio Scientific's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Eurobio Scientific? | Current EBITDA multiple of Eurobio Scientific is 8.0x. |
| What is the current FCF of Eurobio Scientific? | Eurobio Scientific's last 12 months FCF is $22M. |
| What is Eurobio Scientific's FCF margin? | Eurobio Scientific's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Eurobio Scientific? | Current FCF multiple of Eurobio Scientific is 12.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.